PLAY PODCASTS
Standard Deviation S2 EP1: Gatekeepers of the Ivory Tower

Standard Deviation S2 EP1: Gatekeepers of the Ivory Tower

Out of Patients with Matthew Zachary · Matthew Zachary

March 12, 202616m 46sbonusExplicit

Audio is streamed directly from the publisher (pdcn.co) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Science likes to call itself a meritocracy. Angela Anderson and Brandi Mattson know better. Both served as editors at elite journals (Cell and Neuron), where a single decision could determine who gets tenure, funding, or obscurity. They watched brilliant data get filtered out because the authors did not know the unwritten rules controlled by 5 dominant publishing houses with profit margins higher than Google.


In 2020, amid pandemic shutdowns and national reckoning over racial injustice, they co-founded a nonprofit to expose that hidden curriculum. Through the JEDI program, they provide 10 hours of free editorial consulting to scientists who lack access to elite networks. In 1 year alone, 25 awards helped researchers salvage canceled grants, secure NSF career funding, and rebuild careers derailed by rejection.


This episode pulls back the curtain on the multibillion dollar publishing engine that profits from taxpayer funded science and reveals who gets heard, who gets sidelined, and how insiders are choosing to redistribute power.


RELATED LINKS

Angela Anderson

Brandy Mattson

Life Science Editors

Life Science Editors Foundation

Cell

Neuron

National Science Foundation


FEEDBACK

Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email [email protected]

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Topics

moral injuryfuture of healthcaretelemedicinehealthcare costshealth insuranceAI inhealthcareclinical trialsprecision medicinepatient marketingultra rare diseasehealth datapatient rightsbig pharmainsurancechemotherapyimmunotherapycancer researchcaregiversgenetic testingmediacancer risk reductioncancer preventioncancer rightsshared decision makingpharma marketingpharmatelehealthgenomicshealthcare communicationshealth equitywe the patientshealthcare marketingmental healthmedical burnoutoncologyout of patientspatient storytellingearly detectionpublic healthhealthcare reformpalliative carefinancial toxicitypatientshealthcare workforcebioethicshematologyhealth disparitySDOH (Social Determinants of Health)cancer survivorshealthcarehealth literacypharmaceuticalshealthcare policyhealthcare systemmedical debtbiotechhealthcare innovationlife sciencescancer patientspodcastingpatient experiencedigital healthpatient centricitychronic illnessrare diseasecancerpatient storiespatient empowermentpatient advocacymatthew zachary